Bristol Myers-Squibb Names COO
Executive Summary
Bristol-Myers Squibb has appointed Murdo Gordon executive vice president and chief commercial officer, a newly created role. Gordon has been with the global biopharma company since 1989, holding positions of increasing responsibility including senior vice president for US oncology and immunoscience from 2011-2013, and president of US operations. Most recently, he co-led the commercial organisation of the company as head of worldwide markets.
You may also be interested in...
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Changes At The Top At Viatris And Clinuvel Among This Week's Announcements
Recent moves in the industry include C-suite shuffle at Brainstorm Cell Therapeutics and new CFOs at Faron Pharmaceuticals and Foghorn Therapeutics, among others.
Pipeline Watch: Six Approvals And 15 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.